## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `tesamorelin-post-surgery` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/tesamorelin-post-surgery/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-post-surgery/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-post-surgery/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-post-surgery/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-post-surgery/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-post-surgery/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `tesamorelin-post-surgery` v2 · content_hash `a36fdc361c023563…` · thread_head genesis · 22 DIVs - **thesis (c1):** Phase 3 RCTs in HIV patients showed tesamorelin reduced visceral adipose tissue compared with placebo over 26 weeks. - c3 [human/active] No completed human RCTs exist for tesamorelin in post-surgical wound healing or general recovery. - c2 [preclinical/active] Animal studies suggest growth hormone can accelerate axonal regeneration and reduce muscle atrophy after nerve injury. - c4 [anecdotal/active] Reddit users report subjective visceral fat loss and improved workout recovery with tesamorelin. - c5 [speculative/active] A planned clinical trial will test tesamorelin after peripheral nerve injury repair. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-post-surgery/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-post-surgery/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `tesamorelin-post-surgery` - **title:** Tesamorelin for Post-Surgery Recovery: A Data-First Evidence Review - **url:** https://miscsubjects.com/a/tesamorelin-post-surgery - **register:** source_ledger - **updated:** 2026-07-17T02:42:25.289Z - **tags:** peptide, matrix ## Body ## What's breaking down Post-surgery recovery involves multiple layers of tissue response. Surgical trauma disrupts skin, muscle, fascia, nerves, and sometimes bone or tendon continuity. Inflammatory signals rise to clear debris. Then repair pathways activate to rebuild extracellular matrix, restore blood supply, and reconnect nerve endings if cut. Muscle can atrophy from disuse or denervation. Visceral fat accumulation may increase in some patients due to immobility, stress hormones, or changes in metabolism. If repair lags behind breakdown, scar tissue forms instead of functional tissue, strength returns slowly, and function stays limited. Growth hormone pathways influence several of these steps by supporting protein synthesis, collagen production, and cell proliferation in repair sites. ## Why Tesamorelin might help you Tesamorelin is a growth hormone-releasing hormone analog. It binds receptors in the pituitary to increase pulsatile growth hormone release, which in turn raises IGF-1 levels. Therefore for you: If the GH axis layer is part of your post-surgery problem, Tesamorelin is discussed because it targets repair pathways in tissue rather than masking pain or inflammation. 1. Surgical injury reduces local growth factor signaling in some cases. 2. Raising GH and IGF-1 may support satellite cell activity and protein synthesis in muscle and connective tissue. 3. This could favor organized collagen deposition over disorganized scar in animal models of nerve and muscle injury. 4. Visceral fat reduction seen in other contexts might ease mechanical stress on healing abdominal or spinal sites indirectly. 5. The net effect discussed is shifting the balance toward regeneration instead of prolonged degeneration. ## How these fit together Single-compound focus. Tesamorelin addresses the GH axis and visceral fat layer. If your post-surgery profile includes other degeneration layers such as direct inflammation or nerve-specific damage, other compounds would target those separately without overlap in this review. ## What the evidence actually shows Human data come from phase 3 randomized, double-blind, placebo-controlled trials in HIV patients with excess abdominal fat. Two multicenter trials (LIPO-010 and CTR-1011) randomized over 800 participants to 2 mg daily tesamorelin or placebo for 26 weeks. Primary outcome was visceral adipose tissue reduction measured by CT or MRI. Pooled analysis showed statistically significant VAT decrease that was maintained in extension phases up to 52 weeks, with preservation of subcutaneous fat and improvements in body image scores. A separate smaller RCT found modest liver fat reduction. These trials establish human evidence for VAT reduction and IGF-1 elevation but enrolled no post-surgical patients and measured no wound healing or functional recovery endpoints. Preclinical data include animal studies on growth hormone effects after peripheral nerve injury. One research proposal references rodent models showing GH accelerates axonal regeneration and reduces muscle atrophy after nerve transection and repair. A planned human trial (PR212195) tests tesamorelin after peripheral nerve injury repair for motor and sensory outcomes, but results are not yet available. No completed human RCTs exist for tesamorelin in post-surgical wound healing, muscle recovery, or general surgical patients. Anecdotal reports appear on forums but remain unverified. ## What scientists say Published reviews note tesamorelin reliably lowers visceral fat via GH stimulation in specific populations. Authors emphasize the compound's selectivity for visceral over subcutaneous fat and its FDA approval status for HIV lipodystrophy. They highlight lack of data outside that indication and call for studies in other metabolic or recovery settings. Mechanistic papers link GH/IGF-1 to enhanced collagen synthesis and myogenesis but stress these pathways require further clinical validation in surgical contexts. ## What people say on Reddit Users in peptide communities report subjective improvements in body composition and recovery when using tesamorelin. Several describe visible visceral fat loss, higher energy during training, and faster return to lifting after periods of inactivity. One thread mentions better workout recovery and muscle retention while in a deficit. Dosing discussions often reference 1-2 mg daily or near-daily schedules. Side effect mentions are mostly mild injection site reactions. These accounts are self-reported, lack controls, and cannot be confirmed as causal. ## What people say on X Public posts on X are limited and mostly promotional or referencing the same HIV indication data. Occasional mentions tie the compound to general recovery or fat loss goals, but no detailed post-surgical narratives appear in recent searches. Volume of discussion remains low compared with other peptides. ## What we do not know No human trials have tested tesamorelin specifically for post-surgical outcomes such as wound tensile strength, time to return to function, nerve regeneration rates, or complication reduction. Effects on non-HIV surgical populations, different age groups, or combined with standard rehab protocols remain unstudied. Long-term safety beyond 52 weeks in non-HIV users is not established. Whether GH elevation from tesamorelin meaningfully alters scar quality or prevents atrophy after orthopedic or abdominal procedures is speculative at present. ## Safety and limits Human trials report injection site reactions as the most common adverse event. Some participants discontinued due to these or other side effects. Glucose metabolism monitoring is noted because GH can influence insulin sensitivity. The compound carries an FDA label for a narrow indication; use outside that setting lacks regulatory evaluation for safety or efficacy. Individual responses vary, and any consideration requires medical oversight. Evidence does not support claims of guaranteed repair acceleration in surgical settings. ## Claims (5) - **c1** [human w=0.8] Phase 3 RCTs in HIV patients showed tesamorelin reduced visceral adipose tissue compared with placebo over 26 weeks. - who_claims: grok/grok-4.3 - sources: s1 - **c3** [human w=0.8] No completed human RCTs exist for tesamorelin in post-surgical wound healing or general recovery. - who_claims: grok/grok-4.3 - **c2** [preclinical w=0.5] Animal studies suggest growth hormone can accelerate axonal regeneration and reduce muscle atrophy after nerve injury. - who_claims: grok/grok-4.3 - sources: s2 - **c4** [anecdotal w=0.3] Reddit users report subjective visceral fat loss and improved workout recovery with tesamorelin. - who_claims: grok/grok-4.3 - sources: s3 - **c5** [speculative w=0.1] A planned clinical trial will test tesamorelin after peripheral nerve injury repair. - who_claims: grok/grok-4.3 - sources: s2 ## Voxel graph (5 atoms · 9 edges) - full graph: https://miscsubjects.com/api/articles/tesamorelin-post-surgery/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (3) - chain valid: yes · head: `b26b2a772e3a60fe` ### s1 · pubmed · ok - title: Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials - url: https://pubmed.ncbi.nlm.nih.gov/20554713/ - summary: Pooled phase 3 data showing VAT reduction in HIV patients. - quote: Treatment with tesamorelin reduces VAT and maintains the reduction for up to 52 wk - claim_ids: c1 - hash: `c4d52f7ecc29ee26` ### s2 · other · ok - title: Tesamorelin Therapy to Enhance Axonal Regeneration... Following Peripheral Nerve Injury and Repair - url: https://www.foundationforpn.org/wp-content/uploads/2025/01/Tesamorelin-Therapy-to-Enhance-Axonal-Regeneration-Minimize-Muscle-Atrophy-and-Improve-Functional-Outcomes-Following-Peripheral-Nerve-Injury-and-Repair.pdf - summary: Grant proposal citing preclinical nerve injury data and describing planned trial. - quote: animal studies have shown that growth hormone, via its downstream factors, can speed peripheral nerve regeneration following injury and can directly act on muscle to prevent atrophy - claim_ids: c2, c5 - hash: `c737de4c664b4318` ### s3 · reddit · ok - title: Starting Tesamorelin next week. Advice needed - url: https://www.reddit.com/r/Biohackers/comments/1qlnwf7/starting_tesamorelin_next_week_advice_needed/ - summary: User discussion on body composition and recovery effects. - quote: Tesamorelin can be effective for leaning out and supporting lean muscle when combined with regular exercise. - claim_ids: c4 - hash: `b26b2a772e3a60fe` ## Provenance (2 model passes) - chain valid: yes · head: `2db3174500afaf4e` - write · grok/grok-4.3 · 2026-06-29T23:15 · hash `e0b01c9223a5` - voxel_divide · owner · 2026-07-17T02:42 · hash `2db3174500af` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-post-surgery/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/tesamorelin-post-surgery/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-post-surgery","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-post-surgery|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-post-surgery|tier|assertion` - **iMessage ask:** `tesamorelin-post-surgery|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `tesamorelin-post-surgery` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-post-surgery/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-post-surgery/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*